entinostat has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christmas, BJ | 1 |
| Rafie, CI | 1 |
| Hopkins, AC | 1 |
| Scott, BA | 1 |
| Ma, HS | 1 |
| Cruz, KA | 1 |
| Woolman, S | 1 |
| Armstrong, TD | 1 |
| Connolly, RM | 1 |
| Azad, NA | 1 |
| Jaffee, EM | 1 |
| Roussos Torres, ET | 1 |
1 other study available for entinostat and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Pancreatic Ductal; CTLA-4 Antigen; Female; Ge | 2018 |